tradingkey.logo

electroCore, Inc.

ECOR
5.450USD
+0.380+7.50%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
41.61MValor de mercado
PerdaP/L TTM

electroCore, Inc.

5.450
+0.380+7.50%

Mais detalhes de electroCore, Inc. Empresa

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

Informações de electroCore, Inc.

Código da empresaECOR
Nome da EmpresaelectroCore, Inc.
Data de listagemJun 22, 2018
CEOGoldberger (Daniel S)
Número de funcionários73
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 22
Endereço200 Forge Way
CidadeROCKAWAY
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07866
Telefone19732900097
Sitehttps://www.electrocore.com/
Código da empresaECOR
Data de listagemJun 22, 2018
CEOGoldberger (Daniel S)

Executivos da empresa electroCore, Inc.

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
232.27K
+46375.00%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+19011.00%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+19011.00%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+19011.00%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
+30549.00%
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Julie A. Goldstein
Ms. Julie A. Goldstein
Independent Director
Independent Director
--
--
Mr. Joshua S. Lev
Mr. Joshua S. Lev
Chief Financial Officer
Chief Financial Officer
--
--
Mr. James C. Theofilos
Mr. James C. Theofilos
Director
Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
232.27K
+46375.00%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+19011.00%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+19011.00%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+19011.00%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
+30549.00%
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Health and Wellness Products
6.81M
78.37%
Prescription Devices
1.88M
21.63%
Por RegiãoUSD
Nome
Receita
Proporção
United States
8.22M
94.63%
United Kingdom
402.00K
4.63%
Other
48.00K
0.55%
Japan
17.00K
0.20%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Health and Wellness Products
6.81M
78.37%
Prescription Devices
1.88M
21.63%

Distribuição de ações

Atualizado em: sex, 6 de fev
Atualizado em: sex, 6 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
The Vanguard Group, Inc.
3.04%
Outro
72.98%
Investidores
Investidores
Proporção
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
The Vanguard Group, Inc.
3.04%
Outro
72.98%
Tipos de investidores
Investidores
Proporção
Individual Investor
27.86%
Corporation
8.76%
Investment Advisor
7.46%
Investment Advisor/Hedge Fund
1.59%
Hedge Fund
1.57%
Research Firm
0.02%
Outro
52.74%

Participação acionária institucional

Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
75
727.72K
16.70%
--
2025Q3
75
727.72K
17.61%
-444.98K
2025Q2
70
1.17M
19.50%
-199.13K
2025Q1
65
1.37M
13.77%
+380.78K
2024Q4
69
936.59K
18.00%
-138.83K
2024Q3
59
1.06M
17.69%
+20.62K
2024Q2
62
1.04M
19.14%
+51.56K
2024Q1
68
992.08K
19.07%
-152.78K
2023Q4
66
961.96K
18.72%
+22.04K
2023Q3
73
937.71K
13.66%
+316.94K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Zhang (Tianyi)
734.64K
9.19%
+734.64K
--
May 15, 2025
Theofilos (Charles Steve)
444.53K
5.56%
--
--
Jul 04, 2025
Hilve Holdings Ltd
432.00K
5.4%
+432.00K
--
Aug 15, 2025
Errico (Thomas J.)
306.38K
3.83%
+26.61K
+9.51%
Sep 02, 2025
The Vanguard Group, Inc.
233.47K
2.92%
+1.14K
+0.49%
Sep 30, 2025
Goldberger (Daniel S)
185.90K
2.32%
+1.00K
+0.54%
Dec 02, 2025
Happy Holstein Management, LLC
153.17K
1.92%
--
--
Jul 04, 2025
MAZ Partners, L.P.
115.52K
1.44%
-156.44K
-57.52%
May 13, 2025
Patton (Thomas M)
102.78K
1.29%
+19.01K
+22.69%
Sep 02, 2025
Goldstein (Julie Ann)
101.39K
1.27%
+19.01K
+23.08%
Sep 02, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Data
Data ex-dividendo
Tipo
Proporção
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
KeyAI